Blocking FAO with ST1326, a specific CPT1A inhibitor, or with avocatin B reduces cell growth and induces AML cells apoptosis without affecting normal CD34+ hematopoietic cells (53, 54). The gene discussed is CPT1A; the disease is acute myeloid leukemia.